Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology

Urothelial bladder cancer (UBC) is one of the most prevalent and aggressive malignancies. Recent evidence indicates that the tumor microenvironment (TME), including a variety of immune cells, is a critical modulator of tumor initiation, progression, evolution, and treatment resistance. Mast cells (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hae Woong, Naskar, Manisha, Seo, Ho Kyung, Lee, Hye Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614912/
https://www.ncbi.nlm.nih.gov/pubmed/34829729
http://dx.doi.org/10.3390/biomedicines9111500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614912/
https://www.ncbi.nlm.nih.gov/pubmed/34829729
http://dx.doi.org/10.3390/biomedicines9111500

Ejemplares similares